Dexfenfluramine in obesity [Briefing note]

Scottish Health Purchasing Information Centre
Record ID 31999008488
Authors' objectives:

To examine the overall costs and benefits of dexfenfluramine in obesity.

Authors' recommendations: Dexfenfluramine treatment for periods of a year or less does not seem worthwhile, because the weight is replaced when the drug is stopped. Because of lack of evidence regarding long-term safety, it cannot be recommended for long term use. We therefore do not think dexfenfluramine is a cost-effective treatment for obesity.
Authors' methods: Review
Project Status: Completed
Year Published: 1997
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Scotland, United Kingdom
MeSH Terms
  • Costs and Cost Analysis
  • Fenfluramine
  • Appetite Depressants
  • Obesity
Organisation Name: Scottish Health Purchasing Information Centre
Copyright: Scottish Health Purchasing Information Centre
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.